Tevogen Inc. (TVGNW)Warren, United States | NasdaqCM
0.08 USD
+0.01
(22.016%)
⇧
(Oct. 13, 2026, 2:27 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:46 a.m. EDT
The immediate outlook is severely bearish due to a catastrophic balance sheet and liquidity crisis. The company carries nearly $9.5 million in debt against a mere $1 million in cash, resulting in a current ratio of 0.33 and negative book value. This structural insolvency suggests a high probability of distress or delisting, which overrides any potential short-term price spikes. There is no long-term investment case because the business is burning cash aggressively with no revenue history or price trajectory to validate its survival. Furthermore, there is no dividend to speak of, making this a speculative trap rather than an investment opportunity. |
| Attribute | Value |
|---|---|
| Beta | 0.20 |
| Previous Name | Semper Paratus Acquisition Corporation |
| Website | https://tevogen.com |
| Attribute | Value |
|---|---|
| Address1 | 15 Independence Boulevard |
| Address2 | Suite #210 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.203 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | -4.157 |
| City | Warren |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0787 |
| Current Ratio | 0.327 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0787 |
| Day Low | 0.0653 |
| Ebitda | -21,283,812 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0787 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0653 |
| Fifty Two Week Low Change | 0.013399996 |
| Fifty Two Week Low Change Percent | 0.20520666 |
| Fifty Two Week Range | 0.0653 - 0.0787 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 841,617 |
| Free Cashflow | -3,051,937 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | 0.0008000061 |
| Fullday Change Percent | 1.0269655 |
| Fullday Price | 0.0787 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey. |
| Long Name | Tevogen Inc. |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_702249906 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -22,240,424 |
| Open | 0.045 |
| Operating Cashflow | -11,569,983 |
| Operating Margins | 0.0 |
| Phone | 877 838 6436 |
| Prev Name | Semper Paratus Acquisition Corporation |
| Previous Close | 0.0645 |
| Price Hint | 4 |
| Price To Book | -0.018931922 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.202 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.014200002 |
| Regular Market Change Percent | 22.015507 |
| Regular Market Day High | 0.0787 |
| Regular Market Day Low | 0.0653 |
| Regular Market Day Range | 0.0653 - 0.0787 |
| Regular Market Open | 0.045 |
| Regular Market Previous Close | 0.0645 |
| Regular Market Price | 0.0787 |
| Regular Market Time | 1,791,916,045 |
| Regular Market Volume | 204,873 |
| Return On Assets | -2.97366 |
| Sand P52 Week Change | 0.17502642 |
| Sector | |
| Sector Key | |
| Short Name | Semper Paratus Acquisition Corp |
| Source Interval | 15 |
| State | NJ |
| Symbol | TVGNW |
| Total Cash | 1,082,155 |
| Total Cash Per Share | 0.166 |
| Total Debt | 9,442,832 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 204,873 |
| Website | https://tevogen.com |
| Zip | 7,059 |